The striking enrichment of KEAP1 and FBXW7 mutations specifically in Lynch-associated cases, based on the number of mutation events, suggests distinct pathogenic processes compared to MLH1me+ cases, potentially underlying the variable clinical behaviors and treatment responses observed among historically unified MMR-deficient cancers (38). Here, KEAP1 is linked to cancer.